by European Public Health Alliance | Apr 22, 2022 | Antimicrobial Resistance | Latest Developments, Non Communicable Diseases (NCDs), Universal Access and Affordable Medicines
WHO has been seeking public input to support the work of the Intergovernmental Negotiating Body (INB) in drafting and negotiating an international instrument to strengthen pandemic prevention, preparedness and response. In their first round of public hearings on 12-13...
by European Public Health Alliance | Apr 7, 2022 | #A2Medicines, Antimicrobial Resistance | Latest Developments
In an effort to maintain the effectiveness of antimicrobials for humans and animals, and to support the development of new therapeutic and diagnostic tools, the European Commission is working on a proposal for a Council Recommendation on AMR. This initiative is a...
by European Public Health Alliance | Dec 13, 2021 | Universal Access and Affordable Medicines | Latest Developments
As the past 2 years have been dominated by COVID-19, the upcoming revision of the EU pharmaceutical legislation could not come at a more critical time. The pandemic increased the relevance and power of the pharmaceutical industry as a key provider of vaccines and...
by European Public Health Alliance | Sep 2, 2021 | Healthy Environments | Latest Developments, Non Communicable Diseases (NCDs)
EPHA response to the WHO Draft Global Alcohol Action Plan 2022-2030Alcohol is not an ordinary commodity; it is a psychoactive substance with dependence-producing properties. The European Region is not spared by alcohol-related harms with alcohol consumption being one...
by Matteo Barisione | Aug 26, 2021 | Clean Air | Latest Developments, Climate Emergency & EU Green Deal
The 2021 United Nations Climate Change Conference (COP26) in Glasgow in November will be crucial for international climate action. It will have far-reaching consequences for the long-term health of our societies. As the Lancet Countdown 2020 Report explained, no...
